Application of cytokine drug delivery systems to the immunotherapy of renal cell carcinoma in mice

K. Marumo, Mototsugu Oya, M. Murai, H. Tazaki

Research output: Contribution to journalArticle

Abstract

We have investigated the antitumor effects of human lymphoblastoid interferon (HLBI) mini-pellets, interleukin-2 (IL-2) entrapped in liposome (IL-2 liposome) and an immune complex of IL-2 and monoclonal antibody against IL-2 (IC-1). The HLBI mini-pellets were administered to nude mice bearing a human renal cancer cell line (KU-2). HLBI levels remained detectable both in the tumor tissue and the serum up to 10 days after peritumor injection. The HLBI mini-pellet significantly suppressed tumor growth by peritumor administration. The antitumor effect of IL-2 liposome on Renca, a murine renal cancer, resulted in the inhibition of tumor growth. An accumulation of Lyt-2- and L3T4- lymphocytes was seen in the tumor tissue which was treated with IL-2 liposomes. The IC-1 was prepared by mixing IL-2 and anti-IL-2 monoclonal antibody at a molar ratio of 2:1. Plasma IL-2 levels were sustained longer in mice given the IC-1 than in mice given IL-2 alone. The IC-1 complex exerted a more significant antitumor effect by local administration in Renca-bearing mice than the administration of IL-2 alone. We speculated that these effects were a result of sustained tumor IL-2 levels due to the increase in molecular weight. The results we obtained indicate that the cytokine drug delivery system has a long-acting cytotoxicity by administration to the tumor sites through efficient stimulation of the local immune response, and thus provides a useful tool for treatment of renal cell carcinoma.

Original languageEnglish
JournalInternational Journal of Urology
Volume3
Issue numberSUPPL.
Publication statusPublished - 1996

Fingerprint

Drug Delivery Systems
Renal Cell Carcinoma
Immunotherapy
Interleukin-2
Cytokines
Interferon-alpha
Liposomes
Neoplasms
Kidney Neoplasms
Monoclonal Antibodies
Growth
Antigen-Antibody Complex
Nude Mice
Molecular Weight
Lymphocytes
Cell Line
Injections

Keywords

  • Drug delivery system
  • Interferon
  • Interleukin-2
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Urology
  • Medicine(all)

Cite this

Application of cytokine drug delivery systems to the immunotherapy of renal cell carcinoma in mice. / Marumo, K.; Oya, Mototsugu; Murai, M.; Tazaki, H.

In: International Journal of Urology, Vol. 3, No. SUPPL., 1996.

Research output: Contribution to journalArticle

@article{b4ae5dc2ef974c8fb175ded915d97b9a,
title = "Application of cytokine drug delivery systems to the immunotherapy of renal cell carcinoma in mice",
abstract = "We have investigated the antitumor effects of human lymphoblastoid interferon (HLBI) mini-pellets, interleukin-2 (IL-2) entrapped in liposome (IL-2 liposome) and an immune complex of IL-2 and monoclonal antibody against IL-2 (IC-1). The HLBI mini-pellets were administered to nude mice bearing a human renal cancer cell line (KU-2). HLBI levels remained detectable both in the tumor tissue and the serum up to 10 days after peritumor injection. The HLBI mini-pellet significantly suppressed tumor growth by peritumor administration. The antitumor effect of IL-2 liposome on Renca, a murine renal cancer, resulted in the inhibition of tumor growth. An accumulation of Lyt-2- and L3T4- lymphocytes was seen in the tumor tissue which was treated with IL-2 liposomes. The IC-1 was prepared by mixing IL-2 and anti-IL-2 monoclonal antibody at a molar ratio of 2:1. Plasma IL-2 levels were sustained longer in mice given the IC-1 than in mice given IL-2 alone. The IC-1 complex exerted a more significant antitumor effect by local administration in Renca-bearing mice than the administration of IL-2 alone. We speculated that these effects were a result of sustained tumor IL-2 levels due to the increase in molecular weight. The results we obtained indicate that the cytokine drug delivery system has a long-acting cytotoxicity by administration to the tumor sites through efficient stimulation of the local immune response, and thus provides a useful tool for treatment of renal cell carcinoma.",
keywords = "Drug delivery system, Interferon, Interleukin-2, Renal cell carcinoma",
author = "K. Marumo and Mototsugu Oya and M. Murai and H. Tazaki",
year = "1996",
language = "English",
volume = "3",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "SUPPL.",

}

TY - JOUR

T1 - Application of cytokine drug delivery systems to the immunotherapy of renal cell carcinoma in mice

AU - Marumo, K.

AU - Oya, Mototsugu

AU - Murai, M.

AU - Tazaki, H.

PY - 1996

Y1 - 1996

N2 - We have investigated the antitumor effects of human lymphoblastoid interferon (HLBI) mini-pellets, interleukin-2 (IL-2) entrapped in liposome (IL-2 liposome) and an immune complex of IL-2 and monoclonal antibody against IL-2 (IC-1). The HLBI mini-pellets were administered to nude mice bearing a human renal cancer cell line (KU-2). HLBI levels remained detectable both in the tumor tissue and the serum up to 10 days after peritumor injection. The HLBI mini-pellet significantly suppressed tumor growth by peritumor administration. The antitumor effect of IL-2 liposome on Renca, a murine renal cancer, resulted in the inhibition of tumor growth. An accumulation of Lyt-2- and L3T4- lymphocytes was seen in the tumor tissue which was treated with IL-2 liposomes. The IC-1 was prepared by mixing IL-2 and anti-IL-2 monoclonal antibody at a molar ratio of 2:1. Plasma IL-2 levels were sustained longer in mice given the IC-1 than in mice given IL-2 alone. The IC-1 complex exerted a more significant antitumor effect by local administration in Renca-bearing mice than the administration of IL-2 alone. We speculated that these effects were a result of sustained tumor IL-2 levels due to the increase in molecular weight. The results we obtained indicate that the cytokine drug delivery system has a long-acting cytotoxicity by administration to the tumor sites through efficient stimulation of the local immune response, and thus provides a useful tool for treatment of renal cell carcinoma.

AB - We have investigated the antitumor effects of human lymphoblastoid interferon (HLBI) mini-pellets, interleukin-2 (IL-2) entrapped in liposome (IL-2 liposome) and an immune complex of IL-2 and monoclonal antibody against IL-2 (IC-1). The HLBI mini-pellets were administered to nude mice bearing a human renal cancer cell line (KU-2). HLBI levels remained detectable both in the tumor tissue and the serum up to 10 days after peritumor injection. The HLBI mini-pellet significantly suppressed tumor growth by peritumor administration. The antitumor effect of IL-2 liposome on Renca, a murine renal cancer, resulted in the inhibition of tumor growth. An accumulation of Lyt-2- and L3T4- lymphocytes was seen in the tumor tissue which was treated with IL-2 liposomes. The IC-1 was prepared by mixing IL-2 and anti-IL-2 monoclonal antibody at a molar ratio of 2:1. Plasma IL-2 levels were sustained longer in mice given the IC-1 than in mice given IL-2 alone. The IC-1 complex exerted a more significant antitumor effect by local administration in Renca-bearing mice than the administration of IL-2 alone. We speculated that these effects were a result of sustained tumor IL-2 levels due to the increase in molecular weight. The results we obtained indicate that the cytokine drug delivery system has a long-acting cytotoxicity by administration to the tumor sites through efficient stimulation of the local immune response, and thus provides a useful tool for treatment of renal cell carcinoma.

KW - Drug delivery system

KW - Interferon

KW - Interleukin-2

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030482510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030482510&partnerID=8YFLogxK

M3 - Article

C2 - 24304015

AN - SCOPUS:0030482510

VL - 3

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - SUPPL.

ER -